MALAT1 was initially identified in non-small cell lung cancer and subsequently reported to be highly expressed in numerous cancers including but not limited to bladder cancer, gastric cancer, hepatocellular carcinoma, breast cancer, colorectal cancer, ovarian cancer, prostate cancer and renal cell carcinoma [19]. Here, MALAT1 is linked to urinary bladder carcinoma.